SEMPER PARATUS ACQU -CW26 (TVGNW)

0.0548  +0.01 (+10.93%)

SEMPER PARATUS ACQU -CW26

NASDAQ:TVGNW (12/20/2024, 8:00:01 PM)

0.0548

+0.01 (+10.93%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS SectorN/A
GICS IndustryN/A
GICS SubIndustryN/A
Chartmill FA Rating
Valuation
Growth
Profitability
Health
Dividend
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
CRS0
6 Month56.57%
Overview
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Ins OwnersN/A
Inst OwnersN/A
Market Cap0
SharesN/A
PEN/A
Fwd PEN/A
Dividend YieldN/A
AnalystsN/A
Short Float %N/A
Short Ratio0.24
IPON/A N/A
Stock Screener Links
Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

TVGNW Daily chart

TVGNW News

News Image3 days ago - Tevogen Bio IncTevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth Agenda
News Image3 days ago - Tevogen Bio IncTevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth Agenda

WARREN, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty...

News Image5 days ago - Tevogen Bio IncTevogen Bio to Host Panel “Pioneering the Economics of Health: Balancing Access and Outcomes” During the 43rd Annual J.P. Morgan Healthcare Conference
News Image5 days ago - Tevogen Bio IncTevogen Bio to Host Panel “Pioneering the Economics of Health: Balancing Access and Outcomes” During the 43rd Annual J.P. Morgan Healthcare Conference

WARREN, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, announced today that it will host a compelling panel discussion, “Pioneering the Economics of Health: Balancing Access and Outcomes,” during the 43rd Annual J.P. Morgan Healthcare Conference.

News Image12 days ago - Tevogen Bio IncTevogen Bio to Attend the 43rd Annual J.P. Morgan Healthcare Conference
News Image12 days ago - Tevogen Bio IncTevogen Bio to Attend the 43rd Annual J.P. Morgan Healthcare Conference

WARREN, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty...

TVGNW Twits

Here you can normally see the latest stock twits on TVGNW, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example